Utah Medical Products, Inc.

Healthcare

NASDAQ:UTMD · NASDAQ Global Select

Market Cap $221.10M Beta 0.37 P/E (TTM) 19.9

$67.84 -2.30%

-$1.60 today

52W Low $52.00High $71.81

Vol 0.00M · Avg 0.01M

EPS (TTM)$3.41

Div Yield1.81%

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+25.56%

Period High

$70.65

Period Low

$52.83

Latest

$67.84

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Prenetics Global Limited

NASDAQ:PRE

$367.72M

OraSure Technologies, Inc.

NASDAQ:OSUR

$287.79M

Perspective Therapeutics, Inc.

AMEX:CATX

$227.89M

Profound Medical Corp.

NASDAQ:PROF

$200.47M

InfuSystem Holdings, Inc.

AMEX:INFU

$184.46M

KORU Medical Systems, Inc.

NASDAQ:KRMD

$183.73M

Coherus Oncology, Inc.

NASDAQ:CHRS

$171.37M

Protalix BioTherapeutics, Inc.

AMEX:PLX

$168.39M

Neuronetics, Inc.

NASDAQ:STIM

$92.55M

Nyxoah S.A.

NASDAQ:NYXH

$55.05M

What is the latest UTMD filing?

The latest filing shown is 4 dated May 29, 2026.

How many recent filings does UTMD have?

Intrinsic Alpha currently shows 20 recent filings for UTMD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.